JP2017534658A5 - - Google Patents

Download PDF

Info

Publication number
JP2017534658A5
JP2017534658A5 JP2017526551A JP2017526551A JP2017534658A5 JP 2017534658 A5 JP2017534658 A5 JP 2017534658A5 JP 2017526551 A JP2017526551 A JP 2017526551A JP 2017526551 A JP2017526551 A JP 2017526551A JP 2017534658 A5 JP2017534658 A5 JP 2017534658A5
Authority
JP
Japan
Prior art keywords
hydroxyhexahydrofuro
nitrooxy
furan
compound
bis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017526551A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017534658A (ja
JP6820847B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/076865 external-priority patent/WO2016079142A1/en
Publication of JP2017534658A publication Critical patent/JP2017534658A/ja
Publication of JP2017534658A5 publication Critical patent/JP2017534658A5/ja
Application granted granted Critical
Publication of JP6820847B2 publication Critical patent/JP6820847B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017526551A 2014-11-19 2015-11-17 プロスタグランジンと一酸化窒素供与体との組み合わせ Expired - Fee Related JP6820847B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14193883.7 2014-11-19
EP14193883 2014-11-19
PCT/EP2015/076865 WO2016079142A1 (en) 2014-11-19 2015-11-17 Combinations of prostaglandins and nitric oxide donors

Publications (3)

Publication Number Publication Date
JP2017534658A JP2017534658A (ja) 2017-11-24
JP2017534658A5 true JP2017534658A5 (enExample) 2018-12-20
JP6820847B2 JP6820847B2 (ja) 2021-01-27

Family

ID=51904805

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017526551A Expired - Fee Related JP6820847B2 (ja) 2014-11-19 2015-11-17 プロスタグランジンと一酸化窒素供与体との組み合わせ

Country Status (7)

Country Link
US (1) US10610509B2 (enExample)
EP (1) EP3220905B1 (enExample)
JP (1) JP6820847B2 (enExample)
CN (1) CN106999452B (enExample)
CA (1) CA2968010A1 (enExample)
ES (1) ES2764654T3 (enExample)
WO (1) WO2016079142A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019121488A1 (en) * 2017-12-21 2019-06-27 Nicox S.A. Nitric oxide releasing hyaluronic esters
KR102836746B1 (ko) 2018-08-06 2025-07-21 니콕스 에스아 산화질소 방출 포스포디에스테라제 타입 5 억제제
JP7708771B2 (ja) * 2020-02-05 2025-07-15 ニコックス エス.エー. 緑内障及び高眼圧症の処置のための組成物
CN118084895B (zh) * 2024-02-28 2025-09-05 中国药科大学 一种一氧化氮供体型Omidenepag衍生物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002085372A1 (en) * 2001-04-19 2002-10-31 Teika Pharmaceutical Co., Ltd. Medicines and medicinal kits
WO2009098113A1 (en) * 2008-02-07 2009-08-13 Nicox S.A. Nitric oxide donor compounds
EP2911656B1 (en) * 2012-10-23 2020-12-02 Nicox SA Quinone based nitric oxide donating compounds for ophthalmic use

Similar Documents

Publication Publication Date Title
JP2023030072A (ja) 併用療法
ES2399314T3 (es) Gamma lactamas sustituidas como agentes terapeúticos
ES2711425T3 (es) Espesamiento de la córnea central reducido mediante el uso de profármacos de éster hidrófilos de beta-clorociclopentanos
RU2014151622A (ru) Композиции и способы лечения нейродегенеративных заболеваний
JP2017534658A5 (enExample)
JP2013056948A (ja) 安定なプロスタグランジン含有組成物
JP2014502974A5 (enExample)
JP2012507552A (ja) プロスタグラジンのアミノ酸塩
JP2014515383A5 (enExample)
RU2009128968A (ru) Производные изосорбидмононитрата для лечения повышенной внутриглазной гипертензии
ME02608B (me) Kombinacija, komplet i postupak snižavanja intraokularnog pritiska
US9150537B2 (en) Bicyclic compound and use thereof for medical purposes
JP2010514733A5 (enExample)
ES2764654T3 (es) Combinaciones de prostaglandinas y donantes de óxido nítrico
JP2019534296A5 (enExample)
WO2013067409A1 (en) Antimicrobial carboline compounds
JP2016056207A (ja) プロスタグランジンアゴニストのプロドラッグの安定した水性組成物およびその使用方法
JP2020511437A5 (enExample)
ES2717481T3 (es) Engrosamiento corneal central reducido mediante el uso de profármacos de ésteres hidrófilos de beta-clorociclopentanos
KR20140035363A (ko) 안정피로 치료 방법
JP2013510845A5 (enExample)
RU2012124216A (ru) Фармацевтическая комбинация соединения простагландина и nsaid для лечения глаукомы и глазной гипертензии
TWI809021B (zh) 含有FP促效藥及β阻斷藥的青光眼治療劑
JP2019526549A5 (enExample)
ES2757798T3 (es) Profármacos de éster de gamma-lactamas y su uso